Home › Vaso-Occlusive Crises › Maryland
Vaso-Occlusive Crises clinical trials in Maryland
4 studies for Vaso-Occlusive Crises are looking for participants at sites in Maryland.
Cities in Maryland
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- The Johns Hopkins University School of Medicine, Baltimore
RecruitingPhase 3
Ages 12 to 100 · All sexes · Updated Nov 10, 2026 · NCT06439082Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- Center for Cancer and Blood Disorders, Bethesda
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07224360Virtual Reality for SCD VOC
- University of Maryland Medical Center, Stoler Infusion Center, Baltimore
Recruiting
Ages 18 to 88 · All sexes · Updated Oct 16, 2026 · NCT07674277Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Maryland, Baltimore
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Oct 8, 2026 · NCT06699849From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.